XML 16 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Oct. 31, 2020
Nov. 02, 2019
Oct. 31, 2020
Nov. 02, 2019
Income Statement [Abstract]        
Sales $ 85,171 $ 106,581 $ 218,840 $ 342,799
Cost of goods sold including occupancy costs 54,099 62,776 153,057 195,012
Gross profit 31,072 43,805 65,783 147,787
Expenses:        
Selling, general and administrative 32,820 42,108 90,727 134,197
CEO transition costs       702
Impairment of assets (1,135)   15,200  
Exit costs associated with London operations   1,737   1,737
Depreciation and amortization 5,302 6,329 16,374 18,877
Total expenses 36,987 50,174 122,301 155,513
Operating loss (5,915) (6,369) (56,518) (7,726)
Interest expense, net (1,080) (870) (2,873) (2,585)
Loss before provision (benefit) for income taxes (6,995) (7,239) (59,391) (10,311)
Provision (benefit) for income taxes 27 (49) 71 (78)
Net loss $ (7,022) $ (7,190) $ (59,462) $ (10,233)
Net loss per share - basic and diluted $ (0.14) $ (0.14) $ (1.16) $ (0.21)
Weighted-average number of common shares outstanding:        
Basic 51,545 50,089 51,127 49,853
Diluted 51,545 50,089 51,127 49,853